Noteworthy, upon treatment with siRNA PMP22-SQ NPs, the electrophysiological endpoints CMAP and sensory NCV were restored in both CMT1A mouse models and became even comparable to the WT group (Fig. 2c). The gene discussed is PMP22; the disease is Charcot-Marie-Tooth disease type 1A.